Pancreatic Neoplasms: all 3,311 studies
Page 14 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.
- Sirolimus in Treating Patients With Advanced Pancreatic CancerCompletedNCT00499486Phase 2Results posted
- Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryTerminatedNCT00482625Phase 2Results posted
- Dasatinib in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00474812Phase 2Results posted
- Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.CompletedNCT00471146Phase 3Results posted
- Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic CancerTerminatedNCT00470535Phase 2Results posted
- Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic CancerTerminatedNCT00463840Phase 1/2Results posted
- A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and SurvivalCompletedNCT00461708Phase 2Results posted
- Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic CancerCompletedNCT00456599Phase 2Results posted
- Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine CancerCompletedNCT00454363Phase 2Results posted
- BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary CancerTerminatedNCT00447122Phase 1Results posted
- A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer SchemaCompletedNCT00439179Phase 1Results posted
- Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic CancerCompletedNCT00438256Phase 1/2Results posted
- Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic CancerTerminatedNCT00429858Phase 2Results posted
- Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic CancerTerminatedNCT00426127Phase 2Results posted
- A Trial of Chemo & Radiation Therapy for Pancreatic CancerCompletedNCT00424827Phase 2Results posted
- Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas CancerCompletedNCT00417976Phase 2Results posted
- Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic CancerTerminatedNCT00416793Phase 2Results posted
- A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic CarcinomaCompletedNCT00411762Phase 1/2Results posted
- RAD001 in Previously Treated Patients With Metastatic Pancreatic CancerCompletedNCT00409292Phase 2Results posted
- Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00408564Phase 2Results posted
- Talimogene Laherparepvec in Patients With Unresectable Pancreatic CancerCompletedNCT00402025Phase 1Results posted
- Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic CancerCompletedNCT00398086Phase 1/2Results posted
- Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic CancerCompletedNCT00389610Phase 2Results posted
- Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerTerminatedNCT00387348Phase 3Results posted
- Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer PatientsCompletedNCT00383760Phase 2Results posted
- A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic CancerCompletedNCT00383149Phase 2Results posted
- A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid TumorsCompletedNCT00379639Phase 1Results posted
- Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00376948Phase 2Results posted
- Gemcitabine, Bevacizumab and Erlotinib in Pancreatic CancerCompletedNCT00366457Phase 2Results posted
- Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit SmokingCompletedNCT00365508Phase 4Results posted
- Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With GemcitabineCompletedNCT00365144Phase 2Results posted
- Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to ChemotherapyCompletedNCT00363051Phase 2Results posted
- Trilogy Stereotactic Body Radiotherapy for Pancreatic CancerCompletedNCT00350142Phase 2Results posted
- Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer PatientsCompletedNCT00338039Phase 2Results posted
- A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic CancerTerminatedNCT00336700Phase 2Results posted
- Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic CancerCompletedNCT00331682Phase 2Results posted
- Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic CancerTerminatedNCT00326911Phase 2Results posted
- INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM CancerTerminatedNCT00322712Results posted
- Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas CancerCompletedNCT00320749Phase 1Results posted
- ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA)CompletedNCT00313560Phase 2Results posted
- Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerTerminatedNCT00310050Phase 1Results posted
- Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By SurgeryCompletedNCT00305877Phase 2Results posted
- Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00305760Phase 2Results posted
- Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic CancerCompletedNCT00290693Phase 2Results posted
- Individualized Drug Treatment for Treating Patients With Pancreatic CancerTerminatedNCT00276744Phase 2Results posted
- Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic CancerCompletedNCT00267020Phase 2Results posted
- Chemoradiation in Locally Advanced Pancreatic CancerTerminatedNCT00262951Phase 2Results posted
- Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic CancerCompletedNCT00225784Phase 2Results posted
- AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic CancerCompletedNCT00219557Phase 2Results posted
- Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic AdenocarcinomaCompletedNCT00201838Phase 1/2Results posted
- Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)TerminatedNCT00198081Phase 2Results posted
- Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)CompletedNCT00196105Not applicableResults posted
- Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic CancerCompletedNCT00185588Phase 1/2Results posted
- Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic CancerCompletedNCT00161213Phase 2Results posted
- Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00114244Phase 2Results posted
- MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00112580Phase 2Results posted
- Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic CancerCompletedNCT00100815Phase 2Results posted
- Trial of Curcumin in Advanced Pancreatic CancerCompletedNCT00094445Phase 2Results posted
- Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic CancerCompletedNCT00091026Phase 2Results posted
- Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT00089024Phase 2Results posted
- Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the PancreasCompletedNCT00084383Phase 2Results posted
- Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic CancerCompletedNCT00068575Phase 2Results posted
- Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic CancerTerminatedNCT00066677Phase 2Results posted
- Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00057876Phase 3Results posted
- Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00042939Phase 2Results posted
- Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic CancerCompletedNCT00031694Phase 2Results posted
- Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic CancerTerminatedNCT00003531Phase 2Results posted
- Vascular Resection in Robotic Pancreaticoduodenectomy for Pancreatic CancerCompletedNCT07871045
- Postoperative Outcomes After Partial Duodenopancreatectomy Versus Total PancreatectomyCompletedNCT07831694
- Robotic vs Laparoscopic and Open Surgery for Abdominopelvic CancersCompletedNCT07821775
- Integration of Whole-Genome Sequencing PrOfiles and ImmuNe StATus in CancerActive, not recruitingNCT07796594Not applicable
- Safety and Efficacy of EUS-guided Gallbladder Drainage Under Endoscopist-directed Conscious SedationCompletedNCT07704021
- The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant TumorsCompletedNCT07651020
- Oncologic Safety and Lymphadenectomy in Parenchyma-Sparing Resection for SPNCompletedNCT07592663
- Agreement Between Large Language Model-Generated Treatment Recommendations With Guideline-Based and Tumor Board Decisions in Gastrointestinal CancerCompletedNCT07592338
- Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaApproved for marketingNCT07573215
- Pancreatic Resection in Fit Octogenarians With Nonmetastatic Pancreatic CancerCompletedNCT07542782
- Splenic Artery Infusion Chemotherapy vs Systemic Chemotherapy in Advanced Pancreatic Body/Tail CancerCompletedNCT07497204
- Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic CancerWithdrawnNCT07488884Phase 1
- Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPIActive, not recruitingNCT07457541Phase 1
- Surgical Management of Pancreatic Cancer With Liver Metastasis (Oligometastasis)CompletedNCT07446946
- Patients Undergoing Pancreatic Surgery at the Antwerp University Hospital.Active, not recruitingNCT07443761
- The Effect of Celiac Axis Stenosis on Morbidity After Pancreatoduodenectomy - A Prospective StudyActive, not recruitingNCT07412301
- SBRT for Liver Tumors, Liver Metastases, and Pancreatic TumorsCompletedNCT07407257Not applicable
- Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDACNo longer availableNCT07399015
- TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic CancerSuspendedNCT07377526Phase 1/2
- Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic CancerActive, not recruitingNCT07326150
- Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical OutcomesCompletedNCT07252570
- Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line ChemotherapyActive, not recruitingNCT07243288
- Pancreatic Disease Burden in Older Adults (1990-2040)CompletedNCT07177599
- Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility StudySuspendedNCT07173374Phase 1
- Gut Microbiota and Metabolite Signatures Associated With Lymph Node Metastasis in Pancreatic CancerCompletedNCT07161921
- Cohort Study on Nutritional, Metabolic, and Volumetric Assessment After PancreaticoduodenectomyCompletedNCT07159672
- Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncologic OutcomesCompletedNCT07147374
- Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PDCompletedNCT07139236
- Early Treatment ctDNA Dynamics to Predict Response to ChemotherapyActive, not recruitingNCT07122466
- Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsTerminatedNCT07121829Phase 1
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersActive, not recruitingNCT07118176Phase 1
- Multivisceral Oncological Resections Involving the Pancreas - An International Multicenter StudyCompletedNCT07091097
- A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)Active, not recruitingNCT07076121Phase 2/3